XpresSpa Group and Metropolitan Washington Airports Authority Announce the Opening of XpresCheck™ COVID-19 Testing Facilities at Dulles International Airport and Reagan National Airport
“We have seen growing interest from airport customers in having COVID testing in airports, as more countries require visitors to have a negative COVID test prior to traveling,” said
COVID-19 testing options at both airports includes the Rapid Molecular COVID-19 Test, with test results available immediately, and the Polymerase Chain Reaction (PCR) Test, with results available typically in one to three days. Health insurance is not accepted on-site, but documentation will be provided to allow testing claims to be submitted directly to health insurance companies by the passenger. Tests are available on a walk-in basis or by appointments, which can be made by visiting https://www.xprescheck.com/.
Twitter: @xprescheck and Instagram: @realxprescheck
This press release may contain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These include statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology. In particular, these statements include, without limitation, statements about our expectations relating to our new XpresCheck™ concept, being able to expand testing to other communicable diseases as well as administer vaccinations for the seasonal flu, our positioning to be part of the national rollout of various COVID-19 vaccinations as they become available, the degree to which our public testing model assists passengers meet testing requirements in select states and countries, our ability to identify and gain access to the latest and best COVID-19 testing methodologies and equipment, and our ability further expand our initial sites and our overall ability to manage the regulatory challenges associated with this business line. Forward-looking statements relating to expectations about future results or events are based upon information available to
Source: XpresSpa Group, Inc.